Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 35
Filter
Add more filters










Publication year range
1.
Int J Vitam Nutr Res ; 79(2): 87-94, 2009 Mar.
Article in English | MEDLINE | ID: mdl-20108210

ABSTRACT

Carotenoids are colored molecules that are widespread in the plant kingdom, but animals cannot synthesize them. Carotenes are long, apolar molecules which require fully functioning digestive processes to be absorbed properly. Hence they could be interesting markers of intestinal absorption and digestion. Indeed, only few tests are available to assess these processes and only the D-xylose tolerance test is routinely used. However D-xylose is a sugar that tests only the absorption of water-soluble compounds and it only tests duodenal absorption. In this study, we have evaluated carotenoids as markers of digestion and absorption. We compared fasting plasma carotenoids concentrations in 21 control subjects, 20 patients with Crohn's disease, and 18 patients with pancreatic cancer. Crohn's disease alters intestinal absorption while pancreatic cancer decreases pancreatic enzyme secretion thus impairing digestion. Results show that all carotenoids are significantly lower in Crohn's and cancer patients as compared to control subjects and the multifactorial analysis shows that this decrease is mostly independent of dietary intake. Interestingly, maldigestion as seen in pancreatic cancer more strongly influences plasma lutein and lycopene concentrations while malabsorption in Crohn's disease acts on other carotenoids. Thus carotenoids could be interesting alternatives for testing and following patients that are suspected of having malabsorption or maldigestion syndromes.


Subject(s)
Carotenoids/blood , Crohn Disease/blood , Ileitis/blood , Pancreatic Neoplasms/blood , Adult , Aged , Biomarkers/blood , Diet , Digestion , Female , Humans , Intestinal Absorption , Male , Middle Aged , Sex Characteristics , Surveys and Questionnaires
2.
Med Mal Infect ; 38(6): 318-23, 2008 Jun.
Article in French | MEDLINE | ID: mdl-18455339

ABSTRACT

UNLABELLED: Pseudomonas aeruginosa is a Gram-negative bacillus frequently encountered in human diseases. P. aeruginosa produces a large number of secreted and cell associated virulence factors. Their production is coordinated by various systems of gene regulation. The correlation and sequential intervention of regulation systems during a pulmonary infection have not been determined yet. OBJECTIVE: The aim of this study was to analyze the expression of three P. aeruginosa virulence genes (exoS, lasI, and algD) during the first seven days of chronic lung infection. To do so, mice were infected intratracheally with agarose beads containing P. aeruginosa. RESULTS: The results were a progressive decrease of exoS transcription and an increase of algD, and lasI transcription during infection. This dynamic evolution was consistent with the clinical observation, which demonstrated a progressive loss of type III secretion system function and an increase in the mucoid phenotype development in P. aeruginosa strains from cystic fibrosis patients. CONCLUSION: The development of a P. aeruginosa pulmonary chronic infection associates a decrease of gene expression related to a type III secretion system and an increase of alginate production.


Subject(s)
Pseudomonas Infections/physiopathology , Pseudomonas aeruginosa/genetics , Pseudomonas aeruginosa/pathogenicity , Virulence/genetics , Animals , DNA Primers , Disease Models, Animal , Gene Expression Regulation, Bacterial , Mice , Pseudomonas aeruginosa/isolation & purification , Transcription, Genetic
3.
Ann Biol Clin (Paris) ; 63(2): 165-77, 2005.
Article in French | MEDLINE | ID: mdl-15771974

ABSTRACT

Our knowledge about intestinal absorption and cleavage of carotenoids has rapidly grown during the last years. New facts about carotenoid absorption have emerged while some controversies about cleavage are close to end. The knowledge of the absorption and conversion processes is indispensable to understand and interpret the perturbations that can occur in the metabolism of carotenoids and vitamin A. Recently, it has been shown that the absorption of certain carotenoids is not passive - as believed for a long time - but is a facilitated process that requires, at least for lutein, the class B-type 1 scavenger receptor (SR-B1). Various epidemiological and clinical studies have shown wide variations in carotenoid absorption from one subject to another, such differences are now explained by the structure of the concerned carotenoid, by the nature of the food that is absorbed with the carotenoid, by diverse exogenous factors like the intake of medicines or interfering components, by diet factors, by genetic factors, and by the nutritional status of the subject. Recently, the precise mechanism of beta-carotene cleavage by betabeta-carotene 15,15' monooxygenase (EC 1.14.99.36) - formerly called beta-carotene 15,15' dioxygenase (ex EC 1.13.11.21) - has been discovered, and a second enzyme which cleaves asymmetrically the beta-carotene molecule has been found. beta-carotene 15,15' monooxygenase only acts on the 15,15' bond, thus forming two molecules of retinal from one molecule of beta-carotene by central cleavage. Even though the betabeta-carotene 15,15' monooxygenase is much more active on the beta-carotene molecule, a study has shown that it can act on all carotenoids. Searchers now agree that other enzymes that can catalyse an eccentric cleavage of carotenoids probably exist, but under physiological conditions the betabeta-carotene 15,15' monooxygenase is by far the most active, and it is mainly effective in the small bowel mucosa and in the liver. However the conversion of provitamin A carotenoids into vitamin A is only partial, and requires a satisfactory protein status.


Subject(s)
Carotenoids/metabolism , Intestinal Absorption , Vitamin A/metabolism , Animals , Biological Availability , Carotenoids/blood , Cats , Child , Dietary Fiber , Humans , Infant, Newborn , Intestinal Mucosa/enzymology , Intestine, Small/enzymology , Liver/enzymology , Lycopene , Mixed Function Oxygenases/metabolism , Nutritional Status , Pharmacokinetics , Rats , Time Factors , Vitamin A Deficiency/metabolism , Xanthophylls/metabolism
8.
Ann Biol Clin (Paris) ; 58(3): 327-35, 2000.
Article in French | MEDLINE | ID: mdl-10846237

ABSTRACT

The measurement of serum carotenoids by HPLC has been largely improved during the last 10 years. However these techniques still require much time and skills, and direct application of published methods is rarely satisfying. We report here the difficulties that we met to transfer some HPLC methods described in the literature to our laboratories. We propose some solution to overcome the problems that we have encountered, our experience will perhaps help out other biologists. We reported also some results obtained in healthy populations.


Subject(s)
Carotenoids/blood , Chromatography, High Pressure Liquid/instrumentation , Chromatography, High Pressure Liquid/methods , Humans , Quality Control , Reference Values , Reproducibility of Results
9.
Ann Biol Clin (Paris) ; 57(3): 273-82, 1999 May.
Article in French | MEDLINE | ID: mdl-10377477

ABSTRACT

Inverse correlations have been found in most studies on the relationship between dietary intake and plasma concentrations of carotenoids on one side and degenerative diseases such as cancer and cardiovascular diseases on the other side. Protective effects of carotenoids have been found for pathologies of the retina and the skin. Concentrations of these molecules in blood are lower in digestive pathologies and HIV. Short- and long-term toxicity of carotenoids was found to be low. In combination with the beneficial effects found for diets rich in carotenoids, this has initiated trials with relatively high doses of carotenoid supplements. In the study in Linxian (China) in a rural population with poor nutritional status, supplementation with beta-carotene, zinc, selenium and vitamin E lowered total mortality and mortality from stomach cancer. Other studies (ATBC, Caret.) on well-fed subjects did not show beneficial effects on mortality from cancer and cardiovascular diseases. On the contrary, higher mortality and lung cancer incidence was found in supplemented subjects that were also exposed to asbestos and cigarette smoke. In these studies, doses of supplemental beta-carotene were high and varied from 20 to 50 mg/day. One still ongoing study, called Suvimax, doses subjects for eight years with a cocktail of vitamins and minerals including 6 mg per day of beta-carotene. This supplementation with physiologically seen more "normal" doses might give clarity on the question if beta-carotene is the protective factor in fruits and vegetables.


Subject(s)
Anticarcinogenic Agents , Cardiovascular Diseases/prevention & control , Carotenoids , Dietary Supplements , Neoplasms/prevention & control , Vitamin E , Carotenoids/blood , Carotenoids/therapeutic use , China/epidemiology , Humans , Neoplasms/epidemiology , Neoplasms/mortality , Retinal Diseases/prevention & control , Skin Diseases/prevention & control , Vitamin E/blood , Vitamin E/therapeutic use
10.
Ann Biol Clin (Paris) ; 57(2): 169-83, 1999.
Article in French | MEDLINE | ID: mdl-10210743

ABSTRACT

Carotenoids are a family of pigments with at least 600 members. They derive from lycopene after steps of cyclisation, dehydrogenation and oxidation. It is their chemical structure that determines their physiochemical properties and, in part, their biological activities. About 50 carotenoids can be found in human diet and about 20 of them have been found in plasma and tissues. There is no RDA (Recommended Daily Allowance) for carotenoids. Quantities of carotenoids in diet are difficult to estimate, partly because methods used for the establishment of food composition tables were not specific and sensitive enough. Also, given values do not always take into account variations due to season and region of culture. Absorption of beta-carotene in humans has been the subject of numerous studies but only very little is known about other carotenoids. In general, absorption depends on bioavailability from the food matrix and solubility in micelles. After absorption through passive diffusion, carotenoids follow the chylomicrons metabolism. They are taken up by the liver and released in the blood stream in lipoproteins (VLDL). Carotenoids with no-substituted beta-ionone cycles (alpha and beta-carotene and beta-cryptoxanthin) have provitamin A activity. Highest activity has been found for all-trans beta-carotene. Not all steps of vitamin A biosynthesis and metabolism of other carotenoids have been clarified yet. Besides their provitamin A activity, carotenoids have numerous biological functions. They are efficient scavengers of free radicals, particularly of 1O2. In vitro they have been shown to protect LDL. However, results in vivo are inconsistent. Other functions include enhancement of gap junctions, immunomodulation and regulation of enzyme activity involved in carcinogenesis.


Subject(s)
Carotenoids/metabolism , Absorption , Adjuvants, Immunologic/pharmacology , Antioxidants/metabolism , Antioxidants/pharmacology , Biological Availability , Carcinogens/metabolism , Carotenoids/analysis , Carotenoids/blood , Carotenoids/chemistry , Carotenoids/physiology , Cryptoxanthins , Diet , Diffusion , Food Analysis , Free Radical Scavengers/pharmacology , Gap Junctions/physiology , Humans , Lipoproteins, VLDL/blood , Liver/metabolism , Lycopene , Nutrition Policy , Oxidation-Reduction , Reactive Oxygen Species/metabolism , Tissue Distribution , Vitamin A/physiology , Xanthophylls , beta Carotene/analogs & derivatives , beta Carotene/physiology
11.
Glycobiology ; 9(3): 311-21, 1999 Mar.
Article in English | MEDLINE | ID: mdl-10024669

ABSTRACT

Bronchial mucins were purified from the sputum of 14 patients suffering from cystic fibrosis and 24 patients suffering from chronic bronchitis, using two CsBr density-gradient centrifugations. The presence of DNA in each secretion was used as an index to estimate the severity of infection and allowed to subdivide the mucins into four groups corresponding to infected or noninfected patients with cystic fibrosis, and to infected or noninfected patients with chronic bronchitis. All infected patients suffering from cystic fibrosis were colonized by Pseudomonas aeruginosa. As already observed, the mucins from the patients with cystic fibrosis had a higher sulfate content than the mucins from the patients with chronic bronchitis. However, there was a striking increase in the sialic acid content of the mucins secreted by severely infected patients as compared to noninfected patients. Thirty-six bronchial mucins out of 38 contained the sialyl-Lewis x epitope which was even expressed by subjects phenotyped as Lewis negative, indicating that at least one alpha1,3 fucosyltransferase different from the Lewis enzyme was involved in the biosynthesis of this epitope. Finally, the sialyl-Lewis x determinant was also overexpressed in the mucins from severely infected patients. Altogether these differences in the glycosylation process of mucins from infected and noninfected patients suggest that bacterial infection influences the expression of sialyltransferases and alpha1,3 fucosyltransferases in the human bronchial mucosa.


Subject(s)
Bronchi/metabolism , Bronchitis/metabolism , Cystic Fibrosis/metabolism , Mucins/chemistry , Pseudomonas Infections/metabolism , Carbohydrate Sequence , Chronic Disease , Glycosylation , Humans , Lewis Blood Group Antigens , Molecular Sequence Data , Mucins/immunology , N-Acetylneuraminic Acid/analysis , Oligosaccharides/analysis , Oligosaccharides/immunology , Phenotype , Pseudomonas Infections/complications , Sialyl Lewis X Antigen , Sputum/chemistry , Sulfates/analysis
12.
Am J Respir Crit Care Med ; 157(6 Pt 1): 1779-84, 1998 Jun.
Article in English | MEDLINE | ID: mdl-9620905

ABSTRACT

The aim of this study was to test whether changes in mucus surface properties by rhDNase treatment could be related to an increased recovery of phospholipids. Purulent sputa from 18 patients with cystic fibrosis (CF) were incubated with either rhDNase (4 microg/ml) or control excipient. The incubation of mucus samples with rhDNase induced a significant increase (p < 0.002) in the sol phase proportion (33.7 +/- 24.0%) compared with that obtained with excipient (12.6 +/- 12.4%). Phospholipids were recovered in significantly (p < 0.05) greater amounts from both mucus gel and sol phases after incubation with rhDNase. The phosphatidylglycerol content of mucus sol phase was significantly increased by rhDNase (p < 0.03), as well as the mucus gel phase surface properties and transport by ciliary activity and by cough (p < 0.05). The improvement of mucus gel surface properties and transport capacity by ciliary activity were significantly related to the increased recovery of phosphatidylglycerol (r = -0.74, p < 0.03 and r = 0.94, p < 0.05, respectively). These results suggest that rhDNase is able to increase the free water content and alter the phospholipid profile of mucus, with a related improvement in CF mucus transportability.


Subject(s)
Cystic Fibrosis/physiopathology , Deoxyribonucleases/pharmacology , Mucociliary Clearance , Mucus/chemistry , Phospholipids/analysis , Adult , Cystic Fibrosis/metabolism , Elasticity , Female , Humans , Lipids/analysis , Male , Phosphatidylglycerols/analysis , Recombinant Proteins/pharmacology , Viscosity
13.
J Clin Microbiol ; 33(4): 924-9, 1995 Apr.
Article in English | MEDLINE | ID: mdl-7790462

ABSTRACT

Secretion of Pseudomonas aeruginosa elastase, exotoxin A, and alkaline protease in sputum during bronchopulmonary exacerbations was examined in 18 cystic fibrosis patients chronically infected with this microorganism. The patients were studied during one or several exacerbation periods necessitating hospitalizations of 12 to 20 days. In all cases, P. aeruginosa was present in bronchial secretions at admission and was not eradicated after treatment. The P. aeruginosa density decreased significantly after antibiotic therapy but remained greater than 10(6) CFU/g of sputum in most cases. Significant amounts of P. aeruginosa exoproteins were measured in total homogenized bronchial secretions by immunoenzymatic assays. The detection of higher levels of exoproteins at admission, the significant decrease after treatment, and the absence of exoproteins during intercrisis phases constituted arguments for a renewal of virulence of P. aeruginosa during exacerbations. Nevertheless, the concomitant changes in bacteria load and the triggering of the inflammatory process and immune complex formation could also contribute to pulmonary exacerbations.


Subject(s)
ADP Ribose Transferases , Bacterial Toxins , Cystic Fibrosis/complications , Pneumonia/complications , Pneumonia/metabolism , Pseudomonas Infections/complications , Pseudomonas Infections/metabolism , Sputum/metabolism , Virulence Factors , Adolescent , Adult , Anti-Bacterial Agents/therapeutic use , Child , Cystic Fibrosis/microbiology , Endopeptidases/biosynthesis , Exotoxins/biosynthesis , Female , Humans , Kinetics , Male , Pancreatic Elastase/biosynthesis , Pneumonia/microbiology , Pseudomonas Infections/microbiology , Pseudomonas aeruginosa/metabolism , Pseudomonas aeruginosa/pathogenicity , Sputum/microbiology , Pseudomonas aeruginosa Exotoxin A
14.
Eur J Clin Chem Clin Biochem ; 32(12): 893-9, 1994 Dec.
Article in English | MEDLINE | ID: mdl-7696436

ABSTRACT

Using immunoenzymometric assays, the production of elastase, alkaline protease and exotoxin A was determined in culture supernatants of 35 strains of Pseudomonas aeruginosa isolated from patients suffering from cystic fibrosis. The assays were simple, specific, sensitive and reproducible, and permitted the determination of low levels of exoproteins. A large strain variability of exoprotein production was found. Most of the strains secreted all three exoproteins, but six out of the 35 strains (17%) did not secrete at least one of the three (< 0.3 microgram/l). A significant correlation was observed between elastase and exotoxin A productions (r = 0.697, p < 0.001).


Subject(s)
ADP Ribose Transferases , Bacterial Proteins/analysis , Bacterial Toxins , Cystic Fibrosis/microbiology , Exotoxins/analysis , Pseudomonas aeruginosa/chemistry , Serine Endopeptidases/analysis , Virulence Factors , Animals , Antibody Specificity , Electrophoresis, Polyacrylamide Gel , Humans , Immunoblotting , Immunoenzyme Techniques , Pancreatic Elastase , Pseudomonas aeruginosa/enzymology , Rabbits , Sensitivity and Specificity , Sodium Dodecyl Sulfate , Sputum/microbiology , Pseudomonas aeruginosa Exotoxin A
15.
Pathol Biol (Paris) ; 42(5): 505-9, 1994 May.
Article in French | MEDLINE | ID: mdl-7824322

ABSTRACT

The authors have studied the production of exoproteins by Pseudomonas aeruginosa in the sputa of 18 patients suffering from cystic fibrosis, during 29 bronchopulmonary exacerbations and also after the recovery of a stable state. Significant levels of exoproteins were detected but with a large heterogenity of intra and inter individual variations. A significant decrease in the production of the three exoproteins was found after twelve days of antibiotherapy, without any correlation between exoprotein levels and colony forming units in the sputa. During the intercrisis phase, exoproteins levels were practically undetectable. These facts and the good correlation between clinical symptoms support the hypothesis of a renewal of virulence of Pseudomonas aeruginosa during these periods of bronchopulmonary exacerbation in cystic fibrosis.


Subject(s)
Cystic Fibrosis/microbiology , Exotoxins/isolation & purification , Pseudomonas Infections/complications , Pseudomonas aeruginosa/metabolism , Sputum/chemistry , Adolescent , Adult , Child , Chronic Disease , Cystic Fibrosis/complications , Humans , Pseudomonas aeruginosa/enzymology , Pseudomonas aeruginosa/isolation & purification
16.
Am J Respir Cell Mol Biol ; 9(3): 323-34, 1993 Sep.
Article in English | MEDLINE | ID: mdl-8398170

ABSTRACT

We compared the chemical composition of salivary mucin glycopeptides from cystic fibrosis (CF) and from non-CF subjects and the adhesion of Pseudomonas aeruginosa to these different salivary glycopeptides. Three pools of CF saliva, four pools of non-CF saliva, one individual CF saliva, and one individual non-CF saliva were studied. The soluble fraction of the saliva was treated with pronase, and gel filtration was performed to obtain high and low molecular mass salivary mucin glycopeptides. The yield of total glycopeptides was significantly higher from CF than from non-CF saliva. Furthermore, the chemical composition revealed a significantly higher sialic acid content in CF than in non-CF mucin glycopeptides, and higher sulfate and fucose content in CF than in non-CF high molecular mass glycopeptides. We studied the adhesion of a nonmucoid strain of P. aeruginosa (1244), its nonpiliated isogenic derivative, and a mucoid strain (M35) to salivary mucin glycopeptides from patients with CF and from non-CF subjects. The three strains bound significantly more to the CF salivary glycopeptides than to the corresponding non-CF salivary glycopeptides. The nonpiliated isogenic mutant of P. aeruginosa 1244 also bound to CF salivary glycopeptides, suggesting that the adhesion of P. aeruginosa could involve nonpilus adhesions. Furthermore, neuraminidase treatment of CF glycopeptides decreased the adhesion of P. aeruginosa 1244. Altogether these results suggested that differences in mucins may in part explain the specificity of P. aeruginosa for CF.


Subject(s)
Bacterial Adhesion , Carbohydrates/analysis , Cystic Fibrosis/metabolism , Mucins/chemistry , Pseudomonas aeruginosa/physiology , Saliva/chemistry , Carbohydrate Metabolism , Chromatography, Gel , Cystic Fibrosis/microbiology , Electrophoresis, Agar Gel , Electrophoresis, Polyacrylamide Gel , Humans , Mucins/metabolism , Neuraminidase/metabolism , Pseudomonas aeruginosa/metabolism , Saliva/metabolism
17.
J Immunol Methods ; 164(1): 27-32, 1993 Aug 26.
Article in English | MEDLINE | ID: mdl-8360507

ABSTRACT

A direct sandwich enzyme immunoassay was developed in order to quantify Pseudomonas aeruginosa elastase. As a solid phase the wells of a microtitre plate were coated with specific IgG and horseradish peroxidase labelled IgG was used as the second antibody. The detection limit of the assay was 0.26 ng/ml and a good agreement was found with elastolytic activity determined using elastin-Congo red. This assay was simple, specific, sensitive and reproducible, and permits the determination of low levels of elastase.


Subject(s)
Pancreatic Elastase/analysis , Pseudomonas aeruginosa/enzymology , Cystic Fibrosis/microbiology , Enzyme-Linked Immunosorbent Assay , Humans , Pancreatic Elastase/immunology , Pseudomonas aeruginosa/immunology
18.
J Pediatr ; 121(1): 138-41, 1992 Jul.
Article in English | MEDLINE | ID: mdl-1352543

ABSTRACT

Ursodeoxycholic acid, 10 to 20 mg/kg per day, was administered for 1 year to 22 patients with cystic fibrosis and chronic cholestasis, resulting in significantly improved liver enzyme values. However, evidence of cholestasis continued, as shown by the pattern of alkaline phosphatase isoenzymes.


Subject(s)
Cholestasis/drug therapy , Cystic Fibrosis/drug therapy , Liver/drug effects , Ursodeoxycholic Acid/therapeutic use , 5'-Nucleotidase/analysis , Adolescent , Adult , Alanine Transaminase/analysis , Alkaline Phosphatase/analysis , Aspartate Aminotransferases/analysis , Bile Acids and Salts/analysis , Bilirubin/analysis , Child , Cholestasis/enzymology , Chronic Disease , Cystic Fibrosis/enzymology , Female , Humans , Liver/enzymology , Male , gamma-Glutamyltransferase/analysis
19.
Pediatr Pulmonol ; 13(1): 22-7, 1992 May.
Article in English | MEDLINE | ID: mdl-1589308

ABSTRACT

Among the various components of tracheobronchial secretions, lipids and particularly phospholipids have been shown to influence rheological properties of airway secretions in patients with cystic fibrosis. We studied the phospholipid composition of tracheobronchial secretions, collected from patients suffering from cystic fibrosis (CF) and other chronic obstructive pulmonary diseases (COPD), and we analyzed the possible relationship between the phospholipid profile and the wettability of tracheobronchial secretions evaluated by the measurement of contact angle. Although total phospholipid content and contact angle of tracheobronchial secretions were significantly increased (P less than 0.01) in CF compared to COPD, no significant relationship existed between these two parameters. The concentrations of the different phospholipid subclasses were not homogeneously modified according to the origin of the secretions. Compared to COPD secretions, the CF secretions were characterized by a significant (P less than 0.001) increase in rigidifying fractions such as sphingomyelin and phosphatidylserine/phosphatidylinositol and a significant (P less than 0.001) decrease in surface-active fractions, such as phosphatidylcholine and phosphatidylglycerol (PG) (P less than 0.001). In the two groups, the surface-active phospholipid fraction, PG, was negatively correlated to the contact angle of tracheobronchial secretions. These results suggest that a decrease in PG content in CF secretions may be one factor responsible for an increase in their adhesivity to the respiratory mucosa, and, consequently, for mucus stasis and severity of bronchial obstruction in cystic fibrosis.


Subject(s)
Cystic Fibrosis/physiopathology , Lung Diseases, Obstructive/physiopathology , Mucus/chemistry , Mucus/physiology , Phospholipids/analysis , Adolescent , Adult , Aged , Aged, 80 and over , Bronchiectasis/physiopathology , Child , Humans , Middle Aged , Surface Properties
20.
Eur Respir J ; 5(3): 343-58, 1992 Mar.
Article in English | MEDLINE | ID: mdl-1572448

ABSTRACT

Proteins and lipids synthesized by airway secretory cells or transudated are active components in the protection of respiratory epithelium. Proteins and ions are involved in the control of mucus hydration. Secretory proteins, such as secretory immunoglobulin A (IgA), transferrin and lysozyme, participate in the airway antibacterial defence. Other biochemical components found in secretions, such as anti-inflammatory and antioxidant agents as well as antiproteases, contribute significantly to the protection of the underlying epithelium.


Subject(s)
Bronchi/physiology , Lipids/physiology , Mucins/physiology , Mucociliary Clearance/physiology , Mucus/physiology , Peptides/physiology , Trachea/physiology , Water-Electrolyte Balance/physiology , Bronchi/immunology , Bronchi/metabolism , Epithelium/immunology , Epithelium/physiology , Humans , Immunoglobulin A, Secretory/immunology , Lipid Metabolism , Mucins/metabolism , Mucous Membrane/metabolism , Mucous Membrane/physiology , Mucus/immunology , Mucus/metabolism , Peptides/metabolism , Trachea/immunology , Trachea/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...